Daniel Tennenbaum, MD
Articles by Daniel Tennenbaum, MD
Dr. Daniel Tennenbaum interviews Dr. Catherine H. Marshall on trends in managing advanced and metastatic prostate cancer.
Up to one-third of all UTUC patients present with variant histology, such as squamous or micropapillary features.
Andrew Armstrong, MD ScM FACP, is interviewed by Daniel Tennenbaum, MD on new research in phenotypic precision medicine.
Andrew Armstrong, MD ScM FACP, is interviewed by Daniel Tennenbaum, MD on the role of pain in prostate cancer.
Neil Desal, MD, MHS, is interviewed by Daniel Tennenbaum, MD, on the use of PSMA-PET in intermediate risk prostate cancer.
Neil Desal, MD, MHS, is interviewed by Daniel Tennenbaum, MD, on the use of PSMA-PET in intermediate risk prostate cancer.
A guide to hereditary RCCs and their syndromes, as well as the relevant recommended guidelines for diagnosis and management.
Andrew Armstrong, MD ScM FACP, is interviewed by Daniel Tennenbaum, MD on the role of precision medicine in prostate cancer.
Limited evidence of the feasibility of robot-assisted laparoscopic radical nephrectomy with IVC thrombectomy exists.
A report examines the correlation between family history of prostate cancer and risk of progression after prostatectomy.
The standard of care transurethral resection for bladder tumors is compared with en bloc resections for urologic procedures.
Professor Catherine Marshall gives insight on the recent shifts in management of mHSPC and compares therapies.
Early identification of biochemical recurrence is a major challenge for post-radical prostatectomy surveillance.
This article presents an account of the literature on PLGA-based conjugates.
The treatment of CSPC has been revolutionized by the advent of apalutamide and enzalutamide in this setting.
Diagnostic accuracy of 68Ga-PSMA-PET/MRI is comparable with mpMRI for patients undergoing primary staging of prostate cancer.
18F-PSMA-1007 PET/CT successfully detects pathological lesions in patients with high PSA levels after radical prostatectomy.
Researchers say 18F-PSMA-1007 PET/CT can identify distant metastasis in prostate cancer.
This article was originally published here. ...
This article was originally published here. ...
630 Madison Ave.
Manalapan, NJ 07726
© 2024 Mashup Media, LLC. All rights reserved.